STATEMENT: Immunotec begins clinical trials to combat chronic fatigue syndrome

(Information sent by the signatory company).

STATEMENT: Immunotec begins clinical trials to combat chronic fatigue syndrome

(Information sent by the signatory company)

Immunocal is a cysteine-rich whey protein isolate dietary supplement that strengthens the immune system and improves health by helping the body increase glutathione production. This randomized, double-blind clinical trial aims to demonstrate how Immunocal can help chronic fatigue syndrome patients improve their quality of life, sleep and fatigue, thanks to its antioxidant, immuno-regulatory and anti-inflammatory properties.

Madrid, May 8, 2024.- Immunotec, a Canadian laboratory specialized in a whey protein food supplement rich in cysteine, announces a double-blind clinical trial in Spain led by Dr. José Alegre, specialist in Chronic Fatigue Syndrome and in charge of directing the treatment unit for this diagnosis at the Vall D'Hebron hospital. This trial evaluates the effectiveness of increasing glutathione (GSH) naturally - a tripeptide made up of the amino acids glutamic acid, cysteine ​​and glycine - in reducing the symptoms of chronic fatigue syndrome and other signs associated with this silent disease. Today the causes that cause this disease are unknown. It is estimated that the number of people affected in Spain by chronic fatigue syndrome reaches almost 2 million patients. Chronic fatigue, also known as chronic fatigue syndrome (CFS), is a complex and debilitating disease that is characterized by a extreme, persistent tiredness that does not improve with rest and may worsen with physical or mental activity. In addition to fatigue, it causes many other symptoms such as muscle and joint pain, headache, cognitive difficulties, sleep problems and general malaise, among others. Although the causes of this disease are not known, it is believed that a combination of genetic, biological, environmental and psychological factors can contribute to its development. These possible causes include viral or bacterial infections, immune system dysfunction, or hormonal changes. The trial is focused on demonstrating the effectiveness of using Immunocal, one of Immunotec's dietary supplements, to give hope to millions of people in everyone suffering from this disease.Immunocal is a specially prepared and patented non-denatured whey protein isolate enriched with linked cysteine, which strengthens the immune system and improves health. It achieves this by raising glutathione levels in the body, providing the essential amino acids that cells and tissues need, supporting their construction and repair and the production of antibodies. This translates into a strengthening of the immune system, detoxifying the body while building antibodies and protecting it against oxidative stress. Within the Immunocal range, you can find two other revolutionary products and precursors of glutathione, which seek to facilitate healthy aging and improved fitness:•  For healthy aging, Immunocal Platinum, which in addition to the benefits of Immunocal, controls inflammation, strengthens bones and prevents calcium loss, supports healthy kidney function and reduces acidity levels in the body.•  For athletes, Immunocal Sport, which together with the benefits of Immunocal, reduces muscle pain, accelerates recovery after physical activity or injury, maximizes intensity, muscle strength and endurance , in addition to increasing muscle mass.Immunocal has the highest biological value of any edible protein, being completely natural and clinically proven.Immunotec carries out this clinical trial to seek to improve the quality of life of those who suffer from this condition.

Contact Contact name: Havas PR Communication Team Contact description: HAVAS PR Contact telephone number: 914569000

NEXT NEWS